Inmunidad de las Mucosas y Alergia: de la Inmunopatología a la Terapia.
![Foto de Inmunidad de las Mucosas y Alergia: de la Inmunopatología a la Terapia.](/img/uploaded/21C42DF6CDA0E8472C44DA6D4C40ABE3.png)
![Foto de Instituto de Investigación Sanitaria del Hospital Universitario La Paz](/img/noimage_org.png)
Instituto de Investigación Sanitaria del Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria del Hospital Universitario La Paz (22)
2024
-
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264
-
Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease
Gastroenterologia y Hepatologia
-
Human intestinal spirochetosis: an entity associated with sexual transmitted infections
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 5, pp. 231-235
-
Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital
Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 721-726
-
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients
Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182
-
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Pharmaceutics, Vol. 16, Núm. 5
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Current management of bowel failure due to Crohn's disease in Spain: Results of a GETECCU survey
Gastroenterologia y Hepatologia, Vol. 46, Núm. 6, pp. 439-445
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease
Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 109-115
-
Randomized clinical trial evaluating three low-volume preparations for colonoscopy in outpatients with Inflammatory Bowel Disease: the EII-PREP trial
Scandinavian Journal of Gastroenterology, Vol. 58, Núm. 6, pp. 656-663
-
Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective study
Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 8, pp. 444-449
-
Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease
Scientific Reports, Vol. 13, Núm. 1
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Doppler Activity and Ultrasonographic Detection of Intra-Abdominal Fistulas Are Predictors of Surgery in Crohn's Disease
Digestive Diseases, Vol. 39, Núm. 3, pp. 204-210
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
-
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry
Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616
-
Is the degree of i2a recurrence in Crohn's disease secondary to ischemic phenomena?
Revista Espanola de Enfermedades Digestivas, Vol. 113
-
Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey
Inflammatory bowel diseases, Vol. 26, Núm. 8, pp. 1149-1154